Fixed-dose combinations for hypertension

Lancet. 2018 Sep 8;392(10150):819-820. doi: 10.1016/S0140-6736(18)31814-2.

Authors

Sandeep P Kishore¹, Abdul Salam², Anthony Rodgers², Marc G Jaffe³, Tom Frieden⁴

Affiliations

¹ Arnhold Institute for Global Health, Icahn School of Medicine at Mount Sinai Health System and Young Professionals Chronic Disease Network, New York. Electronic address: [email protected].
² The George Institute for Global Health, University of New South Wales, Sydney, NSW, Australia.
³ Resolve To Save Lives, New York, NY, USA; Kaiser Permanente South San Francisco Medical Center, South San Francisco, CA, USA.
⁴ Resolve To Save Lives, New York, NY, USA.

PMID: 30215377
DOI: 10.1016/S0140-6736(18)31814-2

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Angiotensin Receptor Antagonists / therapeutic use
Angiotensin-Converting Enzyme Inhibitors / therapeutic use
Antihypertensive Agents / therapeutic use*
Calcium Channel Blockers / therapeutic use
Diuretics / therapeutic use
Drug Combinations
Global Health*
Humans
Hypertension / drug therapy*

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors
Antihypertensive Agents
Calcium Channel Blockers
Diuretics
Drug Combinations